Magnus Polla

Drug Screening in Human PSC-Cardiac Organoids Identifies Pro-proliferative Compounds Acting via the Mevalonate Pathway

Richard J. Mills, Benjamin L. Parker, Gregory A. Quaife-Ryan et al. · Cell stem cell · 2019 · 290 citations · Full text

Biochemistry, Medicine, Mevalonate Pathway +7

Design and synthesis of potent, orally active, inhibitors of carboxypeptidase U (TAFIa)

Magnus Polla, Louise Tottie, Carita Nordén et al. · Bioorganic & Medicinal Chemistry · 2004 · 56 citations

Medicinal Chemistry, Biochemistry, Natural Sciences +6

The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1

Linda Sundström, Susanna Myhre, Monika Sundqvist et al. · PLoS ONE · 2017 · 51 citations · Full text

Gpr120 Null Mice, Insulin Signaling, Gastrointestinal Peptide Hormone +21

Synthesis of optically active cyclohexenol derivatives via enzyme catalyzed ester hydrolysis of 4-acetoxy-3-methyl-2-cyclohexenone

Magnus Polla, Torbjörn Frejd · Tetrahedron · 1991 · 44 citations

Ester Hydrolysis, Engineering, Heterocyclic +10

Discovery of AZD8165 – a clinical candidate from a novel series of neutral thrombin inhibitors

Kate Abrahamsson, Patrik Andersson, Joakim Bergman et al. · MedChemComm · 2015 · 25 citations

Property Calculations, Clinical Candidate, Pharmacotherapy +19